• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在强制降解研究中通过液相色谱-质谱联用技术鉴定TGR5受体激动剂-ZY12201的降解杂质

Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC-MS technique during force degradation study.

作者信息

Sojitra Chandrakant, Dholakia Chintan, Sudhakar Padmaja, Singh Kumar K, Agarwal Sameer

机构信息

API Division, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8 A, Changodar, Ahmedabad, 382 210 India.

Department of Chemistry, Faculty of Science, M.S. University of Baroda, Baroda, 390 002 India.

出版信息

SN Appl Sci. 2021;3(6):660. doi: 10.1007/s42452-021-04660-y. Epub 2021 May 25.

DOI:10.1007/s42452-021-04660-y
PMID:34056545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8144688/
Abstract

UNLABELLED

Forced degradation study is a systemic characterization of degradation products of active pharmaceutical ingredient (API) at conditions which posses more harsh environment that accelerates degradation of API. Forced degradation and stability studies would be useful in selection of proper, packaging material and storage conditions of the API. These are also useful to demonstrate degradation pathways and degradation products of the API and further characterisation of the degradation products using mass spectrometry. TGR5 is a G protein-coupled receptor, activation of which promotes secretion of glucagon-like peptide-1 (GLP-1) and modulates insulin secretion. The potent and orally bioavailable TGR5 agonist, ZY12201, shows activation of TGR5 which increase secretion of GLP-1 and help in lowering blood glucose level in animal models. Hence it is necessary to establish and study degradation pathway and stability of API for better handling and regulatory approval. Force degradation studies of ZY12201 have shown presence of one oxidative impurity during oxidative degradation in HPLC analysis. The oxidized product is further characterized by LC-MS to elucidate structure of impurity and characterize its degradation pathway.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s42452-021-04660-y.

摘要

未标记

强制降解研究是在比加速活性药物成分(API)降解的更恶劣环境条件下,对API降解产物进行的系统表征。强制降解和稳定性研究对于选择合适的API包装材料和储存条件很有用。这些研究对于证明API的降解途径和降解产物,以及使用质谱对降解产物进行进一步表征也很有用。TGR5是一种G蛋白偶联受体,其激活可促进胰高血糖素样肽-1(GLP-1)的分泌并调节胰岛素分泌。强效且口服生物可利用的TGR5激动剂ZY12201显示出TGR5的激活,这会增加GLP-1的分泌,并有助于降低动物模型中的血糖水平。因此,有必要建立并研究API的降解途径和稳定性,以便更好地处理和获得监管批准。ZY12201的强制降解研究表明,在高效液相色谱分析的氧化降解过程中存在一种氧化杂质。通过液相色谱-质谱联用对氧化产物进行进一步表征,以阐明杂质的结构并表征其降解途径。

补充信息

在线版本包含可在10.1007/s42452-021-04660-y获取的补充材料。

相似文献

1
Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC-MS technique during force degradation study.在强制降解研究中通过液相色谱-质谱联用技术鉴定TGR5受体激动剂-ZY12201的降解杂质
SN Appl Sci. 2021;3(6):660. doi: 10.1007/s42452-021-04660-y. Epub 2021 May 25.
2
ZY12201, A Potent TGR5 Agonist: Identification of a Novel Pan CYP450 Inhibitor Tool Compound for In-Vitro Assessment.ZY12201,一种强效的TGR5激动剂:用于体外评估的新型泛CYP450抑制剂工具化合物的鉴定。
Drug Metab Lett. 2022 Mar 15. doi: 10.2174/1872312815666220315145945.
3
Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.一种强效且口服有效的TGR5受体激动剂的发现。
ACS Med Chem Lett. 2015 Nov 20;7(1):51-5. doi: 10.1021/acsmedchemlett.5b00323. eCollection 2016 Jan 14.
4
Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.跨膜胆汁酸受体TGR5的激活调节胰岛α细胞以促进葡萄糖稳态。
J Biol Chem. 2016 Mar 25;291(13):6626-40. doi: 10.1074/jbc.M115.699504. Epub 2016 Jan 12.
5
Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.TGR5 激动剂通过 GLP-2 依赖途径促进小鼠肠道生长。
Am J Physiol Gastrointest Liver Physiol. 2020 May 1;318(5):G980-G987. doi: 10.1152/ajpgi.00062.2020. Epub 2020 Apr 20.
6
Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice.肠 TGR5 激动剂可改善西方饮食喂养小鼠的肝脂肪变性和胰岛素敏感性。
Am J Physiol Gastrointest Liver Physiol. 2019 Mar 1;316(3):G412-G424. doi: 10.1152/ajpgi.00300.2018. Epub 2019 Jan 3.
7
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
8
Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.胰高血糖素样肽-2 通过一种 TGR5 非依赖、GLP-2R 依赖的途径促进胆囊充盈。
Mol Metab. 2017 Mar 31;6(6):503-511. doi: 10.1016/j.molmet.2017.03.006. eCollection 2017 Jun.
9
Recent Progresses in Analytical Perspectives of Degradation Studies and Impurity Profiling in Pharmaceutical Developments: An Updated Review.近年来药物开发中降解研究和杂质分析的分析方法进展:更新综述。
Crit Rev Anal Chem. 2023;53(5):1094-1115. doi: 10.1080/10408347.2021.2008226. Epub 2022 Feb 2.
10
OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition.OL3是一种新型低吸收的TGR5激动剂,副作用减少,通过对TGR5激活和二肽基肽酶-4(DPP-4)抑制的双重作用降低血糖。
Acta Pharmacol Sin. 2016 Sep;37(10):1359-1369. doi: 10.1038/aps.2016.27. Epub 2016 Jun 6.

引用本文的文献

1
Identification and Structural Characterization of Degradation Products of Linagliptin by Mass Spectrometry Techniques.通过质谱技术鉴定利格列汀的降解产物并进行结构表征。
Int J Mol Sci. 2024 Feb 23;25(5):2591. doi: 10.3390/ijms25052591.

本文引用的文献

1
Investigation of the metabolic stability of olmutinib by validated LC-MS/MS: quantification in human plasma.采用经验证的液相色谱-串联质谱法(LC-MS/MS)研究奥美替尼的代谢稳定性:人血浆中的定量分析。
RSC Adv. 2018 Dec 4;8(70):40387-40394. doi: 10.1039/c8ra08161a. eCollection 2018 Nov 28.
2
Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and toxicity studies of its metabolites.使用液相色谱-串联质谱法(LC-MS/MS)对X-376在人肝微粒体孵育中的I期代谢谱及意外反应性代谢产物进行研究:其代谢产物的生物活化途径阐明及毒性研究
RSC Adv. 2020 Feb 3;10(9):5412-5427. doi: 10.1039/c9ra09115g. eCollection 2020 Jan 29.
3
COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
新型冠状病毒肺炎与糖尿病:从病理生理学到临床管理。
Nat Rev Endocrinol. 2021 Jan;17(1):11-30. doi: 10.1038/s41574-020-00435-4. Epub 2020 Nov 13.
4
Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways.LC-MS/MS 检测和鉴定奥希替尼反应代谢物:生物活化途径的阐明。
J Sep Sci. 2020 Feb;43(4):708-718. doi: 10.1002/jssc.201900818. Epub 2019 Dec 2.
5
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.评估新型 TGR5 激动剂与西他列汀联合用于 2 型糖尿病治疗的可能性。
Bioorg Med Chem Lett. 2018 Jun 1;28(10):1849-1852. doi: 10.1016/j.bmcl.2018.04.011. Epub 2018 Apr 5.
6
Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations.用于测定药物制剂中来曲唑的稳定性指示液相色谱法。
J Pharm Anal. 2012 Aug;2(4):298-305. doi: 10.1016/j.jpha.2012.01.010. Epub 2012 Feb 3.
7
Validated stability indicating methods for determination of nitazoxanide in presence of its degradation products.用于在硝唑尼特存在降解产物的情况下测定硝唑尼特的经验证的稳定性指示方法。
J Pharm Anal. 2012 Apr;2(2):105-116. doi: 10.1016/j.jpha.2011.11.004. Epub 2011 Nov 30.
8
Diabetes mellitus and risk of falls in older adults: a systematic review and meta-analysis.糖尿病与老年人跌倒风险:一项系统评价与荟萃分析
Age Ageing. 2016 Nov;45(6):761-767. doi: 10.1093/ageing/afw140. Epub 2016 Aug 11.
9
Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.一种强效且口服有效的TGR5受体激动剂的发现。
ACS Med Chem Lett. 2015 Nov 20;7(1):51-5. doi: 10.1021/acsmedchemlett.5b00323. eCollection 2016 Jan 14.
10
Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S.G蛋白偶联胆汁酸受体TGR5激活后,胰高血糖素样肽-1(GLP-1)和酪酪肽(PYY)的释放由Epac/磷脂酶C-ε(PLC-ε)途径介导,并受内源性硫化氢(H2S)调节。
Front Physiol. 2014 Nov 3;5:420. doi: 10.3389/fphys.2014.00420. eCollection 2014.